Study Shows Distal Renal Tubular Acidosis Patient Outcomes Vary Across Country Lines

What is Distal Renal Tubular Acidosis? Distal renal tubular acidosis (dRTA) is a rare condition which affects approximately 1 in every 100,000 people worldwide. It is caused by a build up…

Continue Reading Study Shows Distal Renal Tubular Acidosis Patient Outcomes Vary Across Country Lines

Patient Advocate Foundation Provides Co-Pay Relief for Rare Disease Patients

What is the Patient Advocate Foundation? The Patient Advocate Foundation (PAF) is a non-profit, formed in 1994 that has one primary aim- eliminate the barriers to treatment too many patients…

Continue Reading Patient Advocate Foundation Provides Co-Pay Relief for Rare Disease Patients
Passage Bio Receives New Funding to Advance 5 Gene Therapy Projects
Source: Pixabay

Passage Bio Receives New Funding to Advance 5 Gene Therapy Projects

Passsage Bio Passage Bio has just announced that they've received 115.5 million dollars to help advance their development of gene therapies. They will begin by using the funds to further…

Continue Reading Passage Bio Receives New Funding to Advance 5 Gene Therapy Projects

New Device Could Help Langerhans Cell Histiocytosis Patients Monitor Their Own Chemotherapy Treatments

Langerhans Cell Histiocystosis Langerhans Cell Histiocytosis (LCH) Is a rare form of cancer caused by an excessive amount of Langerhan cells in the body. These cells form granulomas which can have a…

Continue Reading New Device Could Help Langerhans Cell Histiocytosis Patients Monitor Their Own Chemotherapy Treatments

Phase 3 Study in Europe Shows Continued Positive Results for Potential New Cystic Fibrosis Treatment

Cystic Fibrosis Cystic fibrosis (CF) is a rare disease caused by the lack (or malfunctioning) of the cystic fibrosis transmembrane conductance regulator (CTFR) protein. This occurs when children inherit a mutated…

Continue Reading Phase 3 Study in Europe Shows Continued Positive Results for Potential New Cystic Fibrosis Treatment
International Phase 2 Clinical Trial Initiated for New Potential Hypoparathyroidism Therapy
Source: Pixabay

International Phase 2 Clinical Trial Initiated for New Potential Hypoparathyroidism Therapy

Hypoparathyroidism Hypoparathyroidism (HP) is caused by low levels of the parathyroid hormone (PTH). Most people develop this disease after thyroid surgery as a result of accidental damage/removal of the parathyroid…

Continue Reading International Phase 2 Clinical Trial Initiated for New Potential Hypoparathyroidism Therapy